Savara Resubmits The Biologics License Application To The U.S. Food And Drug Administration For Molbreevi

Reuters
2025.12.22 13:51
Dec 22 (Reuters) - Savara Inc (SVRA.O) : * SAVARA RESUBMITS THE BIOLOGICS LICENSE APPLICATION (BLA) TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR MOLBREEVI* FOR THE POTENTIAL TREATMENT OF AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS (AUTOIMMUNE PAP) Source text: Further company coverage: (SVRA.O)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer